PayIt hires former Uber disruptive marketing leader as KC govtech startup’s first CMO
August 6, 2019 | Startland News Staff
Kansas City-based govtech startup PayIt is downloading executive expertise from the West Coast, John Thomson said Tuesday, announcing PayIt’s first chief marketing officer — a former leader at Uber.
PayIt’s Elevator Pitch
PayIt is simplifying doing business with state, local, and federal government through its award-winning digital government and payment platform. Along with our government partners, we are transforming the customer experience and making government more modern, convenient, and mobile.
Based in San Francisco, Alexandru Otrezov will lead PayIt’s marketing organization and continue to accelerate the company’s brand and growth efforts, said Thomson, co-founder and CEO of PayIt, a headline-grabbing digital government and payment platform.
“Alex is a world-class marketing executive that cares deeply about PayIt’s mission to ‘Simplify Government,’” he added. “We’re thrilled to have Alex join us at this exciting time as we continue to accelerate the pace of innovation in digitizing government services.”
Otrezov most recently served as head of search and experimentation at Uber, where he led teams responsible for growth across all Uber brands, according to a PayIt press release. He previously worked as senior director of search operations at Expedia, and served in numerous leadership roles at several startups which exited through strategic acquisitions.
“I am extremely excited about the disruptive solution PayIt brings to simplify the customer experience with our government partners,” Otrezov said. “With the help of our experienced leadership team, I am looking forward to introducing our award winning platform into every consumer’s life. I believe that by improving accessibility to government services, we can improve the quality of life for many.”
Led by Thomson and Mike Plunkett, co-founder and COO/CFO, PayIt secured a more than $100 million investment from New York-based Insight Partners in March. Just two months later, the startup received $25 million in follow-on investment by Tampa-based Weatherford Capital.
Thomson indicated in March the company would focus on growing its team to better meet PayIt’s goal to be a transformative force in the govtech space.
Click here to read more about PayIt’s big investment.
Featured Business
2019 Startups to Watch
stats here
Related Posts on Startland News
Best in show: Bar K vies for USA Today’s dog bar prize; here’s how a shared love of dogs is pushing expansion
The human-dog bond — and a desire to embrace it at places like Bar K’s innovative bar, restaurant, and dog park experience — is stronger than today’s often partisan and divisive climate, said David Hensley. “It doesn’t matter your political affiliations … where you’re from, your socioeconomic status,” he said. “Everybody loves dogs, and that…
Firm with deep KC ties wins Small Business of the Year thanks to tenacity, hyperlocal focus
Editor’s note: The Greater Kansas City Chamber of Commerce is a non-financial partner of Startland News, which serves as the media partner for the Small Business Superstars program. A decades-long commitment to Kansas City clients — and the belief that rising tides lift all ships — helped propel Walz Tetrick Advertising to the award stage…
How this genre-hopping KC musician is fighting back against digitized entertainment
A former college football star, Keelon Vann often found himself “running on fumes” as he chased his passion on the field — and on key. “I’d be up playing guitar until 3 a.m., which is not a joke, and somehow make it to 5:30 a.m. workouts the next day,” said Vann, a quarterback at Piper High…
New collaboration will help OP startup 3D bioprint, scale its next-gen biotech solution
A Kansas biotech startup’s new manufacturing partner will boost efforts to automate and mass produce Ronawk’s headline-grabbing Bio-Block technology — a platform that has already accelerated medical advancements in tissue therapy. “Collaboration is critical for turning research advances into commercial therapies rapidly. The complexity and diversity of modalities is so big that nobody can do…